Showing results (101-110 of 123) with videos related to
Sort By:
Pageof 13
Journal of Virology|February 23, 2023
Critical Residues Involved in the Coassembly of L1 and L2 Capsid Proteins of Human Papillomavirus 16Jie Chen, Daning Wang, Zhiping Wang, et al.Proceedings of the National Academy of Sciences of the United States of America|December 11, 2019
Viral neutralization by antibody-imposed physical disruptionQingbing Zheng, Jie Jiang, Maozhou He, et al.Nature Communications|June 7, 2020
Rational design of a multi-valent human papillomavirus vaccine by capsomere-hybrid co-assembly of virus-like particlesDaning Wang, Xinlin Liu, Minxi Wei, et al.Journal of Virology|January 21, 2021
Structural basis for the shared neutralization mechanism of three classes of human papillomavirus type 58 antibodies with disparate modes of bindingMaozhou He, Xin Chi, Zhenghui Zha, et al.NPJ Vaccines|November 1, 2022
Characterization of an Escherichia coli-derived triple-type chimeric vaccine against human papillomavirus types 39, 68 and 70Ciying Qian, Yurou Yang, Qin Xu, et al.Iscience|November 28, 2025
An engineered VSV-vectored rabies vaccine with an RABV-G-L71S mutationMingxi Yue, Yuhe Zhu, Hongchao Wu, et al.Vaccine|October 17, 2022
Characterization and immunogenicity of SARS-CoV-2 spike proteins with varied glycosylationTingting Deng, Tingting Li, Gege Chen, et al.The New England Journal of Medicine|August 30, 2023
Anti-Epstein-Barr Virus BNLF2b for Mass Screening for Nasopharyngeal CancerTingdong Li, Fugui Li, Xiaoyi Guo, et al.Theranostics|May 17, 2021
A SCID mouse-human lung xenograft model of SARS-CoV-2 infectionWenkun Fu, Wei Wang, Lunzhi Yuan, et al.Emerging Microbes & Infections|September 8, 2020
SARS-CoV-2 spike produced in insect cells elicits high neutralization titres in non-human primatesTingting Li, Qingbing Zheng, Hai Yu, et al.Pageof 13